CCL19 Regulation of the Secondary Immune Response

CCL19 二次免疫反应的调节

基本信息

  • 批准号:
    9096831
  • 负责人:
  • 金额:
    $ 37.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-01 至 2019-03-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): When a host (person or animal) is exposed to a substance that causes an immune response, under certain circumstances the body generates antibodies. Although the generation of protective antibodies is the purpose of vaccinations, there is very little understood about the role of chemokines in controlling the numbers and types of antibodies that are produced during the secondary immune response. C-C chemokine receptor 7 is a chemokine receptor that regulates the levels of antibodies made. The goal of our studies is to learn how a host uses C-C chemokine receptor 7 to regulate the levels of antibodies that are made during a secondary immune response. This is important since antibodies provide protection to the host when he/she is exposed to the same substance during a secondary immune response. We hypothesize that loss of CCR7 or signaling to downstream effectors such as ERK5 will disrupt targeting of effector memory T cells leading to increased antibody production following the second exposure to an antigen. With the knowledge we gain we will determine if promoting CCR7 signaling during vaccination against a specific self-antigen, and in the near future, can be used to prevent excessive production of antibodies observed during autoimmune disease.
 描述(申请人提供):当宿主(人或动物)接触到一种引起免疫反应的物质时,在某些情况下,身体会产生抗体。虽然产生保护性抗体是疫苗接种的目的,但人们对趋化因子在控制二次免疫反应期间产生的抗体的数量和类型方面的作用知之甚少。C-C趋化因子受体7是一种趋化因子受体,调节产生的抗体水平。我们研究的目标是了解宿主如何使用C-C趋化因子受体7来调节二次免疫反应期间产生的抗体水平。这一点很重要,因为在二次免疫反应期间,当宿主暴露在同一物质中时,抗体为宿主提供保护。我们假设,CCR7的丢失或向下游效应器(如ERK5)发出的信号将扰乱效应器记忆T细胞的靶向,导致第二次接触抗原后抗体产生增加。随着我们获得的知识,我们将确定在针对特定自身抗原的疫苗接种期间促进CCR7信号传递是否可以用于防止在自身免疫性疾病期间观察到的抗体的过度产生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHARLOTTE M VINES其他文献

CHARLOTTE M VINES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHARLOTTE M VINES', 18)}}的其他基金

Development of a Mouse Model to Study Targeted Therapy to Prevent CNS Invasion by Pediatric T-ALL
开发小鼠模型来研究预防儿童 T-ALL 侵袭中枢神经系统的靶向治疗
  • 批准号:
    10579626
  • 财政年份:
    2022
  • 资助金额:
    $ 37.75万
  • 项目类别:
CCR7 Chemotaxis Regulates Memory T Cell Localization
CCR7 趋化性调节记忆 T 细胞定位
  • 批准号:
    10546442
  • 财政年份:
    2015
  • 资助金额:
    $ 37.75万
  • 项目类别:
CCR7 Chemotaxis Regulates Memory T Cell Localization
CCR7 趋化性调节记忆 T 细胞定位
  • 批准号:
    10341145
  • 财政年份:
    2015
  • 资助金额:
    $ 37.75万
  • 项目类别:
REGULATION OF CCR7 MEDIATED EVENTS IN BREAST CANCER CELLS AND IN T CELLS
乳腺癌细胞和 T 细胞中 CCR7 介导的事件的调节
  • 批准号:
    8168395
  • 财政年份:
    2010
  • 资助金额:
    $ 37.75万
  • 项目类别:
CCR7 REGULATION OF ERK5 PHOSPHORYLATION DURING AN IMMUNE RESPONSE
免疫反应期间 CCR7 对 ERK5 磷酸化的调节
  • 批准号:
    7959691
  • 财政年份:
    2009
  • 资助金额:
    $ 37.75万
  • 项目类别:
DIFFERENTIAL SIGNALING OF CCR7 THROUGH ITS 2 ENDOGENOUS LIGANDS, CCL19 & CCL21
CCR7 通过其 2 个内源配体 CCL19 的差异信号传导
  • 批准号:
    7720544
  • 财政年份:
    2008
  • 资助金额:
    $ 37.75万
  • 项目类别:
CCR7 REGULATION OF IMMUNE AND NON-IMMUNE CELL ADHESION/MIGRATION
CCR7 对免疫和非免疫细胞粘附/迁移的调节
  • 批准号:
    7609894
  • 财政年份:
    2007
  • 资助金额:
    $ 37.75万
  • 项目类别:
REGULATION OF CCR7 MEDIATED ADHESION OF T CELLS THROUGH LFA-1
通过 LFA-1 调节 CCR7 介导的 T 细胞粘附
  • 批准号:
    7381287
  • 财政年份:
    2006
  • 资助金额:
    $ 37.75万
  • 项目类别:
The Role of Arrestins in CCR7 Trafficking
逮捕令在 CCR7 贩运中的作用
  • 批准号:
    6809620
  • 财政年份:
    2005
  • 资助金额:
    $ 37.75万
  • 项目类别:
REGULATION OF CCR7 DURING ?2 INTEGRIN-MEDIATED ADHESION
?2 整合素介导的粘附过程中 CCR7 的调节
  • 批准号:
    7170530
  • 财政年份:
    2005
  • 资助金额:
    $ 37.75万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 37.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 37.75万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 37.75万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 37.75万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 37.75万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 37.75万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 37.75万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 37.75万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 37.75万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 37.75万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了